Prithvi Mruthyunjaya MD, MHS is Associate Professor of Ophthalmology at Stanford Univeristy, member of the Vitreoretinal Surgery Service and is the new Director of Ocular Oncology at the Byers Eye Institute. He is a board certified ophthalmologist who has completed two prestigious fellowships: the first in Vitreoretinal Surgery at Duke University and the second in Ocular Oncology at Moorfields Eye Hospital in London, England.
He cares for patients with conditions related to cancer of the eye in both adults and children–either benign, pre-cancerous, or eye cancer. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body which spread to the eye, Coats’ disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions) and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye related side effects of chemotherapy treatments. He is an expert in using the most advanced diagnostic tests to make a personalized treatment plan for every patient. With his expertise in retinal surgery, he treats patients with a variety of advanced techniques including small instrument tumor biopsy, vitrectomy, and radiation therapy.
As a retinal surgeon, he manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease.
His approach to any patient is to provide customized care for every patient and works closely with other experts at the Stanford Cancer Institute. Dr. Mruthyunjaya is actively involved in research in ocular cancer imaging, genetics, and new modalities of tumor biopsy.
Dr. Sunil Srivastava is a uveitis and vireo-retinal specialist at the Cole Eye Institute at the Cleveland Clinic. He is the current fellowship director of the vitreo-retinal fellowships. He graduated summa cum laude both from Cornell University undergraduate and from SUNY at Buffalo Medical School. He completed his ophthalmology residency at Emory University where he served as chief resident. He pursued and completed two fellowships, one a uveitis/medical retina fellowship at the NEI/NIH and a vitreo-retinal surgical fellowship at Duke University. He previously was on faculty at Emory University prior to joining the Cole Eye Institute in 2010. He has been awarded multiple teaching awards both at Emory and at Cole Eye. He is both a Senior Achievement Award recipient from the American Academy of Ophthalmology and a Senior Honor Award from American Society of Retinal Specialists. He has received multiple Cleveland Clinic Innovations Awards for his work in novel imaging analysis. He has co-authored over 140 publications in peer-reviewed journals and has delivered over 200 lectures at national and international conferences. His current interest include the use of novel imaging in uveitis and retinal diseases, the development imaging outcome measures in uveitis and intraoperative imaging in vireo-retinal surgery.